Byron Lawson - 09 Dec 2022 Form 4 Insider Report for HTG MOLECULAR DIAGNOSTICS, INC

Reporting relationship: SVP/Chief Commercial Officer
Issuer ticker: N/A
Reported as of: 09 Dec 2022
Net transaction value: +$425
SEC form: 4
Accepted by SEC: 13 Dec 2022, 16:41:03 UTC
Prior SEC filing: 22 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Shaun D. McMeans, Attorney-in-Fact

Key filing fact

Byron Lawson filed Form 4 for HTG MOLECULAR DIAGNOSTICS, INC on 13 Dec 2022.

Key facts

This page summarizes Byron Lawson's Form 4 filing for HTG MOLECULAR DIAGNOSTICS, INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Dec 2022, 16:41.

Change

Previous filing in this sequence was filed on 22 Aug 2022.
Current net transaction value: +$425.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HTGMQ transaction

Common Stock

Award

Transaction value: $425
Shares: +1,000
Change %: +20%
Price: $0.4250
Shares after: 6,033
Date: 09 Dec 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 4 is being filed voluntarily to report the acquisition of 1,000 shares by the Reporting Person on December 9, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.